- Home
- TARS vs PTON Comparison
TARS vs PTON Comparison
Compare TARS & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | PTON |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TARS | PTON |
|---|---|---|
| Price | $64.62 | $4.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $77.13 | $9.58 |
| AVG Volume (30 Days) | 518.8K | ★ 15.0M |
| Earning Date | 02-24-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $366,100,000.00 | ★ $2,438,200,000.00 |
| Revenue This Year | $147.71 | $1.45 |
| Revenue Next Year | $53.74 | $1.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 182.44 | N/A |
| 52 Week Low | $38.51 | $4.09 |
| 52 Week High | $85.25 | $10.25 |
Technical Indicators
Market Signals| Indicator | TARS | PTON |
|---|---|---|
| Relative Strength Index (RSI) | 29.94 | 26.86 |
| Support Level | $61.67 | $4.09 |
| Resistance Level | $67.45 | $5.98 |
| Average True Range (ATR) | 2.94 | 0.32 |
| MACD | -0.45 | -0.14 |
| Stochastic Oscillator | 12.06 | 17.00 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.